0001193805-24-000282.txt : 20240228 0001193805-24-000282.hdr.sgml : 20240228 20240228171955 ACCESSION NUMBER: 0001193805-24-000282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vitt Daniel CENTRAL INDEX KEY: 0001773673 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 24697053 MAIL ADDRESS: STREET 1: IMMUNIC AG STREET 2: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 BUSINESS PHONE: (332) 255-9818 MAIL ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 4 1 e619306_4-vitt.xml X0508 4 2024-02-26 0 0001280776 IMMUNIC, INC. IMUX 0001773673 Vitt Daniel 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK NY 10036 1 1 0 0 President and CEO 0 Common Stock 2024-02-26 4 P 0 14000 1.3095 A 390877 I See footnote 14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024. /s/ Daniel Vitt 2024-02-28